Tablet Dissolution Testing

Tablet dissolution testing is a critical quality control test used to assess the rate at which a tablet disintegrates and releases its active pharmaceutical ingredient (API) in a specified dissolution medium. It provides valuable information about the tablet’s drug release profile, which is essential for ensuring the tablet’s bioavailability and effectiveness. Here’s how tablet dissolution testing is performed:

Apparatus and Setup

The dissolution testing is typically conducted using the USP (United States Pharmacopeia) dissolution apparatus. The apparatus consists of a set of dissolution vessels, each containing a specific volume of dissolution medium maintained at a controlled temperature. The tablet is

placed in the dissolution vessel, and a rotating paddle or a basket is used to agitate the dissolution medium to mimic the physiological conditions in the gastrointestinal tract.

Pharma Tip: Preventing Crosslinking in Modified Release Tablets

Sample Preparation

Before conducting the test, the tablet is carefully weighed to ensure accurate drug content. For modified-release tablets or extended-release formulations, the tablet coating may need to be removed before testing to expose the drug core. Additionally, for delayed-release formulations, the tablets may need to be tested in different dissolution media with varying pH values to simulate the conditions in different parts of the gastrointestinal tract.

Test Procedure

Once the dissolution medium is prepared and the apparatus is set up, the dissolution vessel is filled with the specified volume of the dissolution medium. The paddle or basket is then set into motion to maintain constant agitation. The tablet is added to the vessel, and the test begins by taking samples at predetermined time intervals.

Pharma Tip: Troubleshooting Double-Impression Issues in Tablet Pressing

Sample Collection and Analysis

During the test, samples of the dissolution medium are collected at specified time points, usually at regular intervals. The samples are then analyzed to measure the concentration of the API released from the tablet. The analysis is typically performed using a validated analytical method, such as high-performance liquid chromatography (HPLC) or UV spectroscopy, depending on the API’s chemical characteristics.

Calculation of Drug Release

The data obtained from the dissolution test is used to construct a drug release profile over time. The amount of drug released from the tablet at each time point is calculated and expressed as a percentage of the total drug content in the tablet. The dissolution profile helps determine the rate and extent of drug release, which are critical for assessing the tablet’s performance and bioavailability.

Pharma Tip: Capping and Lamination Defects in Tablet Production

Conclusion

Tablet dissolution testing is a vital quality control test in pharmaceutical manufacturing. It provides crucial information about the drug release profile, which is essential for ensuring the tablet’s effectiveness and bioavailability. By following standardized testing procedures and using appropriate dissolution apparatus and analytical methods, pharmaceutical companies can obtain reliable dissolution data to meet regulatory requirements and ensure the quality and performance of their tablet products.